5-Jun-2026
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
Globe Newswire (Fri, 22-May 11:30 AM ET)
Globe Newswire (Thu, 30-Apr 4:43 PM ET)
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
Globe Newswire (Thu, 30-Apr 7:00 AM ET)
Market Chameleon (Tue, 28-Apr 7:08 AM ET)
Market Chameleon (Tue, 28-Apr 3:33 AM ET)
Axogen, Inc. Reports First Quarter 2026 Financial Results
Globe Newswire (Tue, 28-Apr 7:00 AM ET)
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
Globe Newswire (Mon, 20-Apr 4:30 PM ET)
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
Globe Newswire (Tue, 14-Apr 7:00 AM ET)
Market Chameleon (Thu, 4-Dec 5:03 AM ET)
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Axogen trades on the NASDAQ stock market under the symbol AXGN.
As of June 5, 2026, AXGN stock price climbed to $42.80 with 757,320 million shares trading.
AXGN has a beta of 1.50, meaning it tends to be more sensitive to market movements. AXGN has a correlation of 0.11 to the broad based SPY ETF.
AXGN has a market cap of $2.27 billion. This is considered a Mid Cap stock.
Last quarter Axogen reported $61 million in Revenue and $.07 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.14.
In the last 3 years, AXGN traded as high as $45.83 and as low as $3.45.
The top ETF exchange traded funds that AXGN belongs to (by Net Assets): VTI, IWM, VXF, IWO, FESM.
AXGN has outperformed the market in the last year with a price return of +296.3% while the SPY ETF gained +25.6%. AXGN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +46.8% and +4.6%, respectively, while the SPY returned +8.5% and -1.1%, respectively.
AXGN support price is $41.35 and resistance is $43.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AXGN shares will trade within this expected range on the day.